| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in MLYS over the last quarter tilts toward selling: insiders offloaded a net 60,776 shares worth roughly $1.6M. In the past 30 days, 0 insiders bought and 2 sold. The bias lately has been to the sell side.
Not all activity pointed one way: 2 insiders sold in the same window, though all of them still hold shares. Classified under Biotechnology (Health Care sector), MLYS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 7.90M | $202.65M | - | |
| Dir | 5.46M | $139.91M | - | |
| CEO | 603.6K | $15.48M | - | |
| Dir | 588.2K | $15.08M | - | |
| Other | 135.0K | $3.46M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 24, 2024 | Slingsby Brian Taylor48 | Director, 10% Owner | Sell | 550,000 | $13.05 | $7,177,500.00 | -6.0% | +1.5% | +3.7% | |
| Jul 16, 2024 | Rodman David Malcom54 | Chief Medical Officer | Sale+OE | 525 | $15.00 | $7,875.58 | -0.5% | -6.8% | -1.8% | |
| Jul 11, 2024 | Levy Adam Scott | CFO And Secretary | Sell | 10,757 | $13.14 | $141,394.31 | -4.2% | +1.0% | +6.8% | |
| Jul 11, 2024 | Congleton Jon46 | Chief Executive Officer | Sell | 15,746 | $13.34 | $210,075.26 | -1.7% | +1.0% | +6.8% | |
| Jun 20, 2024 | Congleton Jon46 | Chief Executive Officer | Sell | 49,313 | $12.01 | $592,022.00 | -1.7% | -0.2% | +15.1% | |
| Jun 14, 2024 | Congleton Jon46 | Chief Executive Officer | Sell | 72,797 | $12.70 | $924,203.22 | -2.4% | -7.9% | +13.8% | |
| Jun 11, 2024 | Levy Adam Scott | CFO And Secretary | Sell | 96,815 | $12.94 | $1,252,718.33 | -27.5% | -8.9% | +19.7% | |
| May 9, 2024 | Rodman David Malcom54 | Chief Medical Officer | Sale+OE | 100 | $15.00 | $1,500.00 | -0.1% | -21.0% | +2.7% | |
| Feb 12, 2024 | Samsara Biocapital Gp, LLC59 | 10% Owner | Buy | 555,555 | $13.50 | $7,499,992.50 | +12.3% | -12.2% | -34.4% | |
| Nov 22, 2023 | Congleton Jon46 | Chief Executive Officer | Buy | 4,250 | $5.97 | $25,355.93 | +0.4% | +156.7% | +99.2% |